Literature DB >> 9391116

Distinct tyrosine phosphorylation sites in JAK3 kinase domain positively and negatively regulate its enzymatic activity.

Y J Zhou1, E P Hanson, Y Q Chen, K Magnuson, M Chen, P G Swann, R L Wange, P S Changelian, J J O'Shea.   

Abstract

Cytokines are critically important for the growth and development of a variety of cells. Janus kinases (JAKs) associate with cytokine receptors and are essential for transmitting downstream cytokine signals. However, the regulation of the enzymatic activity of the JAKs is not well understood. Here, we investigated the role of tyrosine phosphorylation of JAK3 in regulating its kinase activity by analyzing mutations of tyrosine residues within the putative activation loop of the kinase domain. Specifically, tyrosine residues 980 and 981 of JAK3 were mutated to phenylalanine individually or doubly. We found that JAK3 is autophosphorylated on multiple sites including Y980 and Y981. Compared with the activity of wild-type (WT) JAK3, mutant Y980F demonstrated markedly decreased kinase activity, and optimal phosphorylation of JAK3 on other sites was dependent on Y980 phosphorylation. The mutant Y980F also exhibited reduced phosphorylation of its substrates, gammac and STAT5A. In contrast, mutant Y981F had greatly increased kinase activity, whereas the double mutant, YY980/981FF, had intermediate activity. These results indicate that Y980 positively regulates JAK3 kinase activity whereas Y981 negatively regulates JAK3 kinase activity. These observations in JAK3 are similar to the findings in the kinase that is closely related to the JAK family, ZAP-70; mutations of tyrosine residues within the putative activation loop of ZAP-70 also have opposing actions. Thus, it will be important to determine whether this feature of regulation is unique to JAK3 or if it is also a feature of other JAKs. Given the importance of JAKs and particularly JAK3, it will be critical to fully dissect the positive and negative regulatory function of these and other tyrosine residues in the control of kinase activity and hence cytokine signaling.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9391116      PMCID: PMC28396          DOI: 10.1073/pnas.94.25.13850

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

Review 1.  Protein kinase classification.

Authors:  T Hunter
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

Review 2.  Protein kinase regulation: insights from crystal structure analysis.

Authors:  D O Morgan; H L De Bondt
Journal:  Curr Opin Cell Biol       Date:  1994-04       Impact factor: 8.382

Review 3.  Haemopoietic receptors and helical cytokines.

Authors:  J F Bazan
Journal:  Immunol Today       Date:  1990-10

Review 4.  Cytokine signal transduction.

Authors:  T Kishimoto; T Taga; S Akira
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

Review 5.  The hematopoietin receptor superfamily.

Authors:  D Cosman
Journal:  Cytokine       Date:  1993-03       Impact factor: 3.861

6.  The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction.

Authors:  M Müller; J Briscoe; C Laxton; D Guschin; A Ziemiecki; O Silvennoinen; A G Harpur; G Barbieri; B A Witthuhn; C Schindler
Journal:  Nature       Date:  1993-11-11       Impact factor: 49.962

7.  Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes.

Authors:  M Kawamura; D W McVicar; J A Johnston; T B Blake; Y Q Chen; B K Lal; A R Lloyd; D J Kelvin; J E Staples; J R Ortaldo
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

8.  Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signalling.

Authors:  Y Nakamura; S M Russell; S A Mess; M Friedmann; M Erdos; C Francois; Y Jacques; S Adelstein; W J Leonard
Journal:  Nature       Date:  1994-05-26       Impact factor: 49.962

9.  Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2.

Authors:  J A Johnston; M Kawamura; R A Kirken; Y Q Chen; T B Blake; K Shibuya; J R Ortaldo; D W McVicar; J J O'Shea
Journal:  Nature       Date:  1994-07-14       Impact factor: 49.962

10.  Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway.

Authors:  D Watling; D Guschin; M Müller; O Silvennoinen; B A Witthuhn; F W Quelle; N C Rogers; C Schindler; G R Stark; J N Ihle
Journal:  Nature       Date:  1993-11-11       Impact factor: 49.962

View more
  34 in total

1.  Regulation of the Jak2 tyrosine kinase by its pseudokinase domain.

Authors:  P Saharinen; K Takaluoma; O Silvennoinen
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  A dual role for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-alpha signaling.

Authors:  T C Yeh; E Dondi; G Uze; S Pellegrini
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

3.  Autoinhibition of Jak2 tyrosine kinase is dependent on specific regions in its pseudokinase domain.

Authors:  Pipsa Saharinen; Mauno Vihinen; Olli Silvennoinen
Journal:  Mol Biol Cell       Date:  2003-04       Impact factor: 4.138

4.  Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog.

Authors:  Titus J Boggon; Yiqun Li; Paul W Manley; Michael J Eck
Journal:  Blood       Date:  2005-04-14       Impact factor: 22.113

5.  Hierarchy of protein tyrosine kinases in interleukin-2 (IL-2) signaling: activation of syk depends on Jak3; however, neither Syk nor Lck is required for IL-2-mediated STAT activation.

Authors:  Y J Zhou; K S Magnuson; T P Cheng; M Gadina; D M Frucht; J Galon; F Candotti; R L Geahlen; P S Changelian; J J O'Shea
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

6.  Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active state.

Authors:  Jason H Kurzer; Pipsa Saharinen; Olli Silvennoinen; Christin Carter-Su
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

Review 7.  Janus kinases in immune cell signaling.

Authors:  Kamran Ghoreschi; Arian Laurence; John J O'Shea
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

8.  The Phosphorylated Estrogen Receptor α (ER) Cistrome Identifies a Subset of Active Enhancers Enriched for Direct ER-DNA Binding and the Transcription Factor GRHL2.

Authors:  Kyle T Helzer; Mary Szatkowski Ozers; Mark B Meyer; Nancy A Benkusky; Natalia Solodin; Rebecca M Reese; Christopher L Warren; J Wesley Pike; Elaine T Alarid
Journal:  Mol Cell Biol       Date:  2019-01-16       Impact factor: 4.272

9.  Jak3-independent trafficking of the common gamma chain receptor subunit: chaperone function of Jaks revisited.

Authors:  Sigrun R Hofmann; Albert Q Lam; Stephan Frank; Yong-Jie Zhou; Haydeé L Ramos; Yuka Kanno; Davide Agnello; Richard J Youle; John J O'Shea
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

10.  Tyrosine phosphorylation of Jak2 in the JH2 domain inhibits cytokine signaling.

Authors:  Edward P Feener; Felicia Rosario; Sarah L Dunn; Zlatina Stancheva; Martin G Myers
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.